1. Market Research
  2. > Healthcare Market Trends
  3. > CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France

Summary

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in France. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

France’s population grew from 64 million in 2008 to 65.5 million in 2013, mainly due to a rising life expectancy (INSEE, 2014e). The increasingly elderly population and its associated disease burden have been fueling the growth of the pharmaceutical market, which, although it fell from $48.9 billion in 2008 to $44.1 billion in 2012 at a negative Compound Annual Growth Rate (CAGR) of 1.2% in US dollar terms, increased at a CAGR of 0.7% in euro terms between 2008 and 2013 (INSEE, 2014r). In 2008, the medical device market was worth $12.7 billion, which increased to $15.5 billion in 2013 and is projected to grow at a CAGR of 5.1% to $21.8 billion in 2020.

These positive growth trends can primarily be attributed to -
- Government initiatives in the healthcare sector
- Universal healthcare coverageIncreasingly elderly population

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in France, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market: Sanofi, Pfizer, Novartis, AstraZeneca and Merck; and profiles and SWOT analyses of the major players in the medical device market: Medtronic, F. Hoffmann-La Roche, Siemens Healthcare, Essilor and Abbott
- Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the French healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving France’s healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect France’s healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in France’s healthcare market

Table Of Contents

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - France
1 Table of Contents
2 Introduction 20
2.1 GlobalData Report Guidance 20
3 Overview of Pharmaceutical and Medical Device Market 21
3.1 Pharmaceutical Market 21
3.1.1 Market Overview 21
3.1.2 Pharmaceutical Exports and Imports 23
3.1.3 Supply Channels 25
3.1.4 Market Segments 26
3.1.5 Major Therapeutic Areas 33
3.1.6 Major Players 36
3.2 Medical Device Market 77
3.2.1 Market Overview 77
3.2.2 Overview of Top Five Segments 79
3.2.3 Diagnostics Market 94
3.2.4 Major Players 96
3.3 Market Drivers and Barriers 129
3.3.1 Drivers 129
3.3.2 Barriers 131
4 Market Access 133
4.1 Reimbursement and Payer Landscape 133
4.1.1 Overview of Healthcare system 133
4.1.2 Reimbursement Process 135
4.1.3 Overview of Insurance Providers 141
4.1.4 Patient Share in Healthcare Expenditure 145
4.1.5 Price Trends in the Healthcare Sector 147
4.1.6 Pricing Policies 148
4.2 Regulatory Landscape 150
4.2.1 Overview of Regulatory Agencies 150
4.2.2 Market Authorization Procedure for Pharmaceutical Products 151
4.2.3 New Medical Device Approval Process 161
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 165
4.2.5 Exports and Imports 166
4.2.6 Intellectual Property Rights 167
4.2.7 Clinical Trial Regulations 172
4.2.8 Pharmaceutical Advertising Regulations 172
4.2.9 Pharmacy Regulations 173
4.2.10 Labeling and Packaging Regulations 175
5 Country Analysis 177
5.1 Political Environment 177
5.1.1 Political Structure 177
5.1.2 Analysis of Current Political Environment 178
5.1.3 Healthcare Policy Initiatives 179
5.2 Economic Landscape 181
5.3 Economic Indicators 182
5.3.1 Gross Domestic Product 182
5.3.2 Gross National Income 186
5.3.3 Inflation 187
5.3.4 Currency Exchange Rate 192
5.3.5 Foreign Direct Investment 193
5.3.6 Foreign Exchange Reserves 195
5.3.7 Trade Balance 196
5.3.8 Government Structural Balance 198
5.3.9 Government Net Debt 200
5.3.10 Major Industries 201
5.4 Demographics 202
5.4.1 Population 202
5.4.2 Education and Literacy 220
5.4.3 Employment 223
5.4.4 Disease Burden 225
5.5 Healthcare Infrastructure 226
5.5.1 Healthcare Facilities 226
5.5.2 Healthcare Parameters 231
5.5.3 Environmental Health 233
5.5.4 Healthcare Personnel 240
5.6 Healthcare Expenditure 244
5.6.1 Overview 244
5.6.2 Share of Public and Private Sectors 245
5.6.3 Major Components of Healthcare Expenditure 247
5.6.4 Spending in Pharmaceutical RandD 248
5.7 Trade Associations 250
5.7.1 France Biotech 250
5.7.2 French Medical Device Association 251
5.7.3 French Pharmaceutical Association 251
5.8 Trade Fairs 252
6 Opportunities and Challenges 253
6.1 Opportunities 253
6.2 Challenges 254
7 Appendix 256
7.1 Abbreviations 256
7.2 Bibliography 260
7.3 Research Methodology 276
7.3.1 Coverage 276
7.3.2 Secondary Research 277
7.3.3 Forecasts 277
7.3.4 Expert Panel 277
7.4 Disclaimer 278

1.1 List of Tables

Table 1: Pharmaceutical Market, France, Revenue ($bn), 2008-2013 22
Table 2: Pharmaceutical Market, France, Revenue Forecast ($bn), 2014-2020 23
Table 3: Pharmaceutical Market, France, Exports and Imports ($bn), 2008-2013 24
Table 4: Pharmaceutical Market, France, Distribution Channels (%), 2009 26
Table 5: Pharmaceutical Market, France, Generic Pharmaceutical Market Share (%), 2008-2013 28
Table 6: Pharmaceutical Market, France, Major Generic Products, Volume (million boxes), 2012 28
Table 7: Pharmaceutical Market, France, Major Generic Products, Value ($m), 2012 28
Table 8: Pharmaceutical Market, France, OTC Drug Market Revenue ($bn), 2008-2013 31
Table 9: Pharmaceutical Market, France, Major OTC Drug Classes, Revenue ($m) and Share (%), 2013 32
Table 10: Pharmaceutical Market, France, Major Therapeutic Areas, Revenue Share (%), 2011 34
Table 11: Pharmaceutical Market, Sanofi, Global, Major Products, 2013 37
Table 12: Pharmaceutical Market, Sanofi, Global, Late-stage Pipeline, 2014 38
Table 13: Pharmaceutical Market, Pfizer, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 43
Table 14: Pharmaceutical Market, Pfizer, Global, Late-Stage Pipeline, 2014 44
Table 15: Pharmaceutical Market, Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 51
Table 16: Pharmaceutical Market, Novartis, Global, Planned Filings, 2014-2018 52
Table 17: Pharmaceutical Market, AstraZeneca, Global, Major Products by Therapy Area, Revenue ($bn) and Annual Growth (%), 2013 62
Table 18: Pharmaceutical Market, AstraZeneca, Global, Late-stage Pipeline*, 2014 63
Table 19: Pharmaceutical Market, Merck, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2013 70
Table 20: Pharmaceutical Market, Merck, Global, Late-Stage Pipeline, 2014 71
Table 21: Medical Device Market, France, Revenue ($bn), 2008-2013 78
Table 22: Medical Device Market, France, Revenue Forecast ($bn), 2014-2020 79
Table 23: Medical Device Market, France, Revenue by Segment, 2013 80
Table 24: Medical Device Market, France, In Vitro Diagnostics Device Market ($m), 2008-2013 82
Table 25: Medical Device Market, France, In Vitro Diagnostics Device Market, Sales Trends for Major Players, 2012 83
Table 26: Medical Device Market, France, Cardiovascular Device Market ($m), 2008-2013 84
Table 27: Medical Device Market, France, Cardiovascular Device Market, Sales Trends for Major Players, 2012 85
Table 28: Medical Device Market, France, Ophthalmic Device Market ($m), 2008-2013 87
Table 29: Medical Device Market, France, Ophthalmic Device Market, Sales Trends for Major Players, 2012 88
Table 30: Medical Device Market, France, Orthopedic Device Market ($m), 2008-2013 90
Table 31: Medical Device Market, France, Orthopedic Device Market, Sales Trends for Major Players ($m), 2012 91
Table 32: Medical Device Market, France, Hospital Supplies Market ($m), 2008-2013 93
Table 33: Medical Device Market, France, Hospital Supplies Market, Sales Trends for Major Players ($m), 2012 94
Table 34: Medical Device Market, France, Diagnostics Market, Revenue ($bn), 2008-2013 95
Table 35: Medical Device Market, France, Diagnostic Market Revenue, Forecast ($bn), 2014-2020 96
Table 36: Medical Device Market, France, Major Medical Device Companies, Revenue ($m) and Share (%), 2012 97
Table 37: Medical Device Market, Medtronic, Global, Major Products, 2013 99
Table 38: Medical Device Market, F. Hoffmann-La Roche, Global, Major Products, 2014 107
Table 39: Medical Device Market, Abbott, Global, Major Products, 2013 123
Table 40: Medical Device Market, Abbott, Global, Late-Stage Pipeline, 2014 124
Table 41: Market Access, France, Drug Reimbursement Categories and Rates (%), 2011 140
Table 42: Market Access, France, Source of Public Health Insurance Funding (%), 2013 144
Table 43: Healthcare Expenditure, France, Out-of-Pocket Expenditure (%), 2008-2013 146
Table 44: Market Access, France, Healthcare Consumer Price Index Annual Change (%), 2008-2013 148
Table 45: Market Access, France, Patent Application Fee € ($), 2014 168
Table 46: Market Access, France, Trademark Registration Fee € ($), 2014 171
Table 47: Market Access, France, Pharmacist Requirement by Revenue of Pharmacy ($m), 2014 174
Table 48: Economic Indicators, France, GDP per Capita ($), 2008-2013 183
Table 49: Economic Indicators, France, GDP per Capita ($), Forecast, 2014-2020 184
Table 50: Economic Indicators, France, GDP Annual Growth (%), 2008-2013 185
Table 51: Economic Indicators, France, GDP Annual Growth (%), Forecast, 2014-2020 186
Table 52: Economic Indicators, France, GNI per Capita ($), 2008-2013 187
Table 53: Economic Indicators, France, Consumer Price Index, 2008-2013 188
Table 54: Economic Indicators, France, Average Consumer Price Index, Forecast, 2014-2020 189
Table 55: Economic Indicators, France, Average Consumer Price Index Annual Change (%), 2008-2013 190
Table 56: Economic Indicators, France, Average Consumer Price Index, Annual Change (%), Forecast, 2014-2020 191
Table 57: Economic Indicators, France, Currency Exchange Rate (€/$), 2008-2013 193
Table 58: Economic Indicators, France, Foreign Direct Investment ($bn), 2008-2013 194
Table 59: Economic Indicators, France, Foreign Exchange Reserves ($bn), 2008-2013 195
Table 60: Economic Indicators, France, Imports of Goods and Services ($bn), 2008-2013 197
Table 61: Economic Indicators, France, Exports of Goods and Services ($bn), 2008-2013 198
Table 62: Economic Indicators, France, General Government Structural Balance ($bn), 2008-2013 199
Table 63: Economic Indicators, France, General Government Net Debt ($bn), 2008-2013 200
Table 64: Economic Indicators, France, Major Industries, Industrial Sector, Gross Value Added ($bn), 2011-2012 202
Table 65: Demographics, France, Population (million), 2008-2013 203
Table 66: Demographics, France, Population Forecast (million), 2014-2020 204
Table 67: Demographics, France, Population, Urban and Rural Population Share (%), 2008-2013 205
Table 68: Demographics, France, Population, Urban and Rural Population Forecast Share (%), 2014-2020 206
Table 69: Demographics, France, Population Distribution by Age Group (%), 2008-2013 208
Table 70: Demographics, France, Population Distribution by Age Group Forecast (%), 2014-2020 208
Table 71: Demographics, France, Births (per 1,000 Population), 2008-2013 210
Table 72: Demographics, France, Mortality (per 1,000 Population), 2008-2013 211
Table 73: Demographics, France, Major Causes of Mortality (%), 2008 212
Table 74: Demographics, France, Children Table 75: Demographics, France, Immunization Rate (%), 2008-2013 215
Table 76: Demographics, France, Major Causes of Male Mortality (per 1,000 population), 2008 216
Table 77: Demographics, France, Major Causes of Female Mortality (per 1,000 population), 2008 217
Table 78: Demographics, France, Gender Ratio (M/F), 2008-2013 218
Table 79: Demographics, France, Life Expectancy at Birth (Years), 2008-2013 220
Table 80: Demographics, France, Number of Students by Level of Education (million), 2013-2014 222
Table 81: Demographics, France, Student Enrollment by Specialization (per 1,000 population), 2013 223
Table 82: Demographics, France, Unemployment Rate (%), 2008-2013 224
Table 83: Demographics, France, Major Diseases, DALYs (per 100,000 Population), 2004 226
Table 84: Healthcare Infrastructure, France, Public and Private Hospitals, 2008-2013 227
Table 85: Healthcare Infrastructure, France, Public and Private Hospitals Beds (‘000), 2008-2013 228
Table 86: Healthcare Infrastructure, France, Diagnostic Centers, 2008-2013 229
Table 87: Healthcare Infrastructure, France, Diagnostic Units, 2008-2013 230
Table 88: Healthcare Infrastructure, France, Hospitals Beds (per 1,000 Population), 2008-2013 232
Table 89: Healthcare Infrastructure, France, Physicians (per 1,000 Population), 2008-2013 233
Table 90: Healthcare Infrastructure, France, PM10 (µg/m³), 2008-2013 234
Table 91: Healthcare Infrastructure, France, CO2 Emissions (Million Metric Tons), 2008-2013 235
Table 92: Healthcare Infrastructure, France, Nitrates and Orthophosphates Content (%), 2008-2013 237
Table 93: Healthcare Infrastructure, France, Solid Waste (Million Tons), 2008-2013 238
Table 94: Healthcare Infrastructure, France, Nature of Collected Waste (%), 2010 239
Table 95: Healthcare Infrastructure, France, Waste Handling (%), 2012 240
Table 96: Healthcare Infrastructure, France, Nurses (per 100,000 Population), 2008-2013 241
Table 97: Healthcare Infrastructure, France, Pharmacists (per 100,000 Population), 2008-2013 242
Table 98: Healthcare Infrastructure, France, Dentists (per 100,000 Population), 2008-2013 243
Table 99: Healthcare Infrastructure, France, Healthcare Expenditure (% of GDP), 2008-2013 245
Table 100: Healthcare Infrastructure, France, Public-Private Share (%), 2008-2013 246
Table 101: Healthcare Infrastructure, France, Major Components of Healthcare Expenditure (%), 2012 247
Table 102: Healthcare Infrastructure, France, Pharmaceutical RandD Expenditure ($bn), 2008-2013 249
Table 103: Healthcare Infrastructure, France, Pharmaceutical RandD Expenditure (%), 2011 250
Table 104: Trade Fairs, France, Major Healthcare Trade Fairs, 2014 252

1.2 List of Figures

Figure 1: Pharmaceutical Market, France, Revenue ($bn), 2008-2013 22
Figure 2: Pharmaceutical Market, France, Revenue Forecast ($bn), 2014-2020 23
Figure 3: Pharmaceutical Market, France, Exports and Imports ($bn), 2008-2013 24
Figure 4: Pharmaceutical Market, France, Distribution Channels (%), 2009 25
Figure 5: Pharmaceutical Market, France, Generic Pharmaceutical Market Share (%), 2008-2013 27
Figure 6: Pharmaceutical Market, France, OTC Drug Market Revenue ($bn), 2008-2013 31
Figure 7: Pharmaceutical Market, France, Major OTC Drug Classes, Revenue ($m), 2013 32
Figure 8: Pharmaceutical Market, France, Major Therapeutic Areas, Revenue Share (%), 2011 33
Figure 9: Medical Device Market, France, Revenue ($bn), 2008-2013 78
Figure 10: Medical Device Market, France, Revenue Forecast ($bn), 2014-2020 79
Figure 11: Medical Device Market, France, Revenue by Segment ($bn), 2013 80
Figure 12: Medical Device Market, France, In Vitro Diagnostics Device Market ($m), 2008-2013 81
Figure 13: Medical Device Market, France, In Vitro Diagnostics Device Market, Sales Trends for Major Players, 2008-2012 82
Figure 14: Medical Device Market, France, Cardiovascular Device Market ($m), 2008-2013 84
Figure 15: Medical Device Market, France, Cardiovascular Device Market, Sales Trends for Major Players, 2008-2012 85
Figure 16: Medical Device Market, France, Ophthalmic Device Market ($m), 2008-2013 87
Figure 17: Medical Device Market, France, Ophthalmic Device Market, Sales Trends for Major Players, 2008-2012 88
Figure 18: Medical Device Market, France, Orthopedic Device Market ($m), 2008-2013 90
Figure 19: Medical Device Market, France, Orthopedic Device Market, Sales Trends for Major Players ($m), 2008-2012 91
Figure 20: Medical Device Market, France, Hospital Supplies Market ($m), 2008-2013 92
Figure 21: Medical Device Market, France, Hospital Supplies Market, Sales Trends for Major Players ($m), 2008-2012 93
Figure 22: Medical Device Market, France, Diagnostics Market, Revenue ($bn), 2008-2013 95
Figure 23: Medical Device Market, France, Diagnostic Market Revenue, Forecast ($bn), 2014-2020 96
Figure 24: Medical Device Market, France, Major Medical Device Companies, Revenue ($m), 2012 97
Figure 25: Healthcare Market, France, Drivers and Barriers, 2014 132
Figure 26: Market Access, France, Healthcare System, 2014 134
Figure 27: Market Access, France, Key Influencers in Reimbursement Procedure, 2014 135
Figure 28: Market Access, France, Pricing and Reimbursement Process, 2014 136
Figure 29: Market Access, France, Roles of Transparency Commission in Reimbursement Procedure, 2014 138
Figure 30: Market Access, France, Pricing Procedure, 2014 140
Figure 31: Market Access, France, Public Health Insurance Schemes, 2011 143
Figure 32: Market Access, France, Source of Public Health Insurance Funding (%), 2013 144
Figure 33: Healthcare Expenditure, France, Out-of-Pocket Expenditure (%), 2008-2013 146
Figure 34: Market Access, France, Healthcare Consumer Price Index Annual Change (%), 2008-2013 147
Figure 35: Market Access, France, Organizational Structure of the Drug Regulatory Authority, 2014 151
Figure 36: Market Access, EU, Centralized Procedure for Market Authorization, Pre-Submission, 2012 155
Figure 37: Market Access, EU, Centralized Procedure, Market Authorization, Pre-Opinion Phase, 2012 156
Figure 38: Market Access, EU, Centralized Procedure, Market Authorization, Post-Opinion Phase, 2012 157
Figure 39: Market Access, EU, Decentralized Procedure, Market Authorization, 2012 159
Figure 40: Market Access, EU, Mutual Recognition Procedure, Market Authorization, 2012 160
Figure 41: Market Access, EU, Conformity Assessment of Class I Medical Devices, 2014 162
Figure 42: Market Access, EU, Conformity Assessment of Class IIa Medical Devices, 2014 163
Figure 43: Market Access, EU, Conformity Assessment of Class IIb Medical Devices, 2014 164
Figure 44: Market Access, EU, Conformity Assessment of Class III Medical Devices, 2014 165
Figure 45: Market Access, France, Patent Approval Process, 2014 169
Figure 46: Market Access, France, Trademark Approval Process, 2014 171
Figure 47: Economic Indicators, France, GDP Per Capita ($), 2008-2013 183
Figure 48: Economic Indicators, France, GDP per Capita ($), Forecast, 2014-2020 184
Figure 49: Economic Indicators, France, GDP Annual Growth (%), 2008-2013 185
Figure 50: Economic Indicators, France, GDP Annual Growth (%), Forecast, 2014-2020 186
Figure 51: Economic Indicators, France, GNI per Capita ($), 2008-2013 187
Figure 52: Economic Indicators, France, Consumer Price Index, 2008-2013 188
Figure 53: Economic Indicators, France, Average Consumer Price Index, Forecast, 2014-2020 189
Figure 54: Economic Indicators, France, Average Consumer Price Index, Annual Change (%), 2008-2013 190
Figure 55: Economic Indicators, France, Average Consumer Price Index, Annual Change (%), Forecast, 2014-2020 191
Figure 56: Economic Indicators, France, Currency Exchange Rate (€/$), 2008-2013 192
Figure 57: Economic Indicators, France, Foreign Direct Investment ($bn), 2008-2013 194
Figure 58: Economic Indicators, France, Foreign Exchange Reserves ($bn), 2008-2013 195
Figure 59: Economic Indicators, France, Imports of Goods and Services ($bn), 2008-2013 196
Figure 60: Economic Indicators, France, Exports of Goods and Services ($bn), 2008-2013 198
Figure 61: Economic Indicators, France, Government Structural Balance ($bn), 2008-2013 199
Figure 62: Economic Indicators, France, General Government Net Debt ($bn), 2008-2013 200
Figure 63: Economic Indicators, France, Major Industries, Industrial Sector, Gross Value Added ($bn), 2011-2012 201
Figure 64: Demographics, France, Population (million), 2008-2013 203
Figure 65: Demographics, France, Population Forecast (million), 2014-2020 204
Figure 66: Demographics, France, Population, Urban and Rural Population Share (%), 2008-2013 205
Figure 67: Demographics, France, Population, Urban and Rural Population Share Forecast (%), 2014-2020 206
Figure 68: Demographics, France, Population Distribution by Age Group (%), 2008-2013 207
Figure 69: Demographics, France, Population Distribution by Age Group Forecast (%), 2014-2020 208
Figure 70: Demographics, France, Births (per 1,000 Population), 2008-2013 209
Figure 71: Demographics, France, Mortality (per 1,000 Population), 2008-2013 210
Figure 72: Demographics, France, Major Causes of Mortality (%), 2008 212
Figure 73: Demographics, France, Children Figure 74: Demographics, France, Immunization Rate (%), 2008-2013 215
Figure 75: Demographics, France, Major Causes of Male Mortality (per 1,000 population), 2008 216
Figure 76: Demographics, France, Major Causes of Female Mortality (per 1,000 population), 2008 217
Figure 77: Demographics, France, Gender Ratio (M/F), 2008-2013 218
Figure 78: Demographics, France, Life Expectancy at Birth (Years), 2008-2013 220
Figure 79: Demographics, France, Number of Students by Level of Education (million), 2013-2014 221
Figure 80: Demographics, France, Student Enrollment by Specialization (per 1,000 population), 2013 222
Figure 81: Demographics, France, Unemployment Rate (%), 2008-2013 224
Figure 82: Demographics, France, Major Diseases, DALYs (per 100,000 Population), 2004 225
Figure 83: Healthcare Infrastructure, France, Public and Private Hospitals, 2008-2013 227
Figure 84: Healthcare Infrastructure, France, Public and Private Hospitals Beds (‘000), 2008-2013 228
Figure 85: Healthcare Infrastructure, France, Diagnostic Centers, 2008-2013 229
Figure 86: Healthcare Infrastructure, France, Diagnostic Units, 2008-2013 230
Figure 87: Healthcare Infrastructure, France, Hospitals Beds (per 1,000 Population), 2008-2013 231
Figure 88: Healthcare Infrastructure, France, Physicians (per 1,000 Population), 2008-2013 232
Figure 89: Healthcare Infrastructure, France, PM10 (µg/m³), 2008-2013 234
Figure 90: Healthcare Infrastructure, France, CO2 Emissions (Million Metric Tons), 2008-2013 235
Figure 91: Healthcare Infrastructure, France, Nitrate and Orthophosphate Content (%), 2008-2013 237
Figure 92: Healthcare Infrastructure, France, Solid Waste (Million Tons), 2008-2013 238
Figure 93: Healthcare Infrastructure, France, Nature of Collected Waste (%), 2010 239
Figure 94: Healthcare Infrastructure, France, Waste Handling (%), 2012 240
Figure 95: Healthcare Infrastructure, France, Nurses (per 100,000 Population), 2008-2013 241
Figure 96: Healthcare Infrastructure, France, Pharmacists (per 100,000 Population), 2008-2013 242
Figure 97: Healthcare Infrastructure, France, Dentists (per 100,000 Population), 2008-2013 243
Figure 98: Healthcare Infrastructure, France, Healthcare Expenditure (% of GDP), 2008-2013 245
Figure 99: Healthcare Infrastructure, France, Public-Private Share (%), 2008-2013 246
Figure 100: Healthcare Infrastructure, France, Major Components of Healthcare Expenditure (%), 2012 247
Figure 101: Healthcare Infrastructure, France, Pharmaceutical RandD Expenditure ($bn), 2008-2013 249
Figure 102: Healthcare Infrastructure, France, Pharmaceutical RandD Expenditure (%), 2011 250
Figure 103: Healthcare Market, France, Opportunities and Challenges, 2014 255

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitor

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitor

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-El ...

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monit

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monit

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro- ...

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitorin

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitorin

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.